Impact Biomedical Inc
IBO0.733USD
+0.332+83.25%
Close 05/02, 16:00（ET）Quotes delayed by 15 min
8.43MMarket Cap
LossP/E TTM
More Details of Impact Biomedical Inc Company
Impact Biomedical, Inc. is a biotechnology company engaged in discovering, developing, and patenting healthcare solutions. It discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. It has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. It also evaluates additional technologies.
Company Info
Company codeIBO
Company nameImpact Biomedical Inc
IPO dateSep 16, 2024
Founded at2018
CEOMr. Frank D. Heuszel, CPA
Number of employees2
Security typeOrdinary Share
Fiscal year-endSep 16
Address1400 Broadfield Blvd.
CityHOUSTON
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code77084
Phone15852321500
Websitehttps://www.impactbiomedinc.com/
Company codeIBO
IPO dateSep 16, 2024
Founded at2018
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Director
Director
182.00
--
Mr. David K. Keene
Mr. David K. Keene
Independent Director
Independent Director
--
--
Mr. Frank D. Heuszel, CPA
Mr. Frank D. Heuszel, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Christian Zimmerman
Mr. Christian Zimmerman
Independent Director
Independent Director
--
--
Mr. Mark Suseck
Mr. Mark Suseck
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Melissa Sims
Ms. Melissa Sims
Director
Director
--
--
Dr. Elise Brownell
Dr. Elise Brownell
Director
Director
--
--
Mr. Castel B. Hibbert
Mr. Castel B. Hibbert
Independent Director
Independent Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Director
Director
182.00
--
Mr. David K. Keene
Mr. David K. Keene
Independent Director
Independent Director
--
--
Mr. Frank D. Heuszel, CPA
Mr. Frank D. Heuszel, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Christian Zimmerman
Mr. Christian Zimmerman
Independent Director
Independent Director
--
--
Mr. Mark Suseck
Mr. Mark Suseck
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Melissa Sims
Ms. Melissa Sims
Director
Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Sat, May 3
Update time: Sat, May 3
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Alset Inc
21.19%
Alset International Ltd.
12.86%
Chan (Heng Fai Ambrose)
2.91%
Document Security Systems, Inc.
1.51%
The Vanguard Group, Inc.
1.04%
Other
60.50%
Shareholder Statistics
Shareholder
Proportion
Alset Inc
21.19%
Alset International Ltd.
12.86%
Chan (Heng Fai Ambrose)
2.91%
Document Security Systems, Inc.
1.51%
The Vanguard Group, Inc.
1.04%
Other
60.50%
Type
Shareholder
Proportion
Corporation
35.56%
Individual Investor
3.70%
Investment Advisor/Hedge Fund
1.30%
Investment Advisor
0.34%
Hedge Fund
0.03%
Other
59.07%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
24
9.75M
80.71%
+3.70M
2024Q4
21
6.56M
57.06%
+6.27M
2024Q3
14
6.41M
55.73%
+6.41M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Chan (Heng Fai Ambrose)
4.27M
35.32%
-300.00K
-6.57%
Mar 31, 2025
Document Security Systems, Inc.
1.57M
13.02%
-105.82K
-6.30%
Mar 27, 2025
The Vanguard Group, Inc.
128.43K
1.06%
--
--
Jan 31, 2025
Heuszel (Frank D.)
97.53K
0.81%
+500.00
+0.52%
Dec 05, 2024
Ferguson Wellman Capital Management, Inc.
36.36K
0.3%
--
--
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
6.00
0%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
20.77K
0.17%
+20.77K
--
Dec 31, 2024
State Street Global Advisors (US)
11.17K
0.09%
+11.17K
--
Dec 31, 2024
View more
Related ETFs
Update time: Fri, May 2
Update time: Fri, May 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data